LivsMed

LivsMed is a South Korea-founded medical device company focused on minimally invasive surgical instruments for laparoscopy. Its core commercial franchise is ArtiSential, a line of handheld articulating laparoscopic instruments designed to deliver wrist-like dexterity and tactile feedback without the capital intensity of robotic systems. The company has expanded this platform with products including ArtiSential 5 and ArtiSeal, and has also disclosed a surgical robotics roadmap featuring STARK for remote robotic surgery. LivsMed operates internationally with offices in Korea, the United States, and Germany, and commercializes products through direct operations and distributors. The company completed a KOSDAQ IPO in 2026 and is positioning itself as a medtech platform company in minimally invasive surgery.